HOUSTON, Jan. 23,
2024 /PRNewswire/ -- Nutex Health Inc. ("Nutex
Health" or the "Company") (NASDAQ: NUTX), today announced that it
has entered into a securities purchase agreement with a single
healthcare focused institutional investor whereby the investor has
agreed to purchase 66,666,666 shares of common stock and warrants
to purchase up to an aggregate of 66,666,666 shares of common stock
at a purchase price of $0.15 per
share and accompanying warrant in a registered direct offering. The
warrants have an exercise price of $0.15 per share, are exercisable immediately, and
will expire five years following the date of issuance.
Maxim Group LLC is acting as the sole placement agent in
connection with the offering.
The gross proceeds to Nutex Health are estimated to be
$10.0 million before deducting the
placement agent fees and other offering expenses. The offering is
expected to close on or about January 25,
2024, subject to the satisfaction of customary closing
conditions.
The offering is being made pursuant to an effective shelf
registration statement on Form S-3 (File No. 333-270886) previously
filed with the U.S. Securities and Exchange Commission ("SEC"),
which was declared effective on April 7,
2023. The securities may be offered only by means of the
prospectus supplement and the accompanying prospectus that form a
part of the registration statement. Copies of the final prospectus
supplement and accompanying prospectus relating to the registered
direct offering may be obtained, when available, by contacting
Maxim Group LLC, at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus
Department, or by telephone at (212) 895-3745 or by email at
syndicate@maximgrp.com. A final prospectus supplement related to
the offering will be filed with the SEC and will be available free
of charge by visiting EDGAR on the SEC's website at
www.sec.gov.
This press release does not constitute an offer to sell or the
solicitation of an offer to buy these securities, nor shall there
be any sale of these securities in any state or other jurisdiction
in which such offer, solicitation or sale would be unlawful prior
to the registration or qualification under the securities laws of
any such state or other jurisdiction. Any offers, solicitations or
offers to buy, or any sales of securities will be made in
accordance with the registration requirements of the Securities Act
of 1933, as amended.
About Nutex Health Inc.:
Headquartered in Houston, Texas
and founded in 2011, Nutex Health Inc. (NASDAQ: NUTX) is a
healthcare management and operations company with two divisions: a
Hospital Division and a Population Health Management Division.
Forward-Looking Statements
Certain statements and information included in this press
release constitute "forward-looking statements" within the meaning
of the Private Securities Litigation Act of 1995. When used in this
press release, the words or phrases "will", "will likely result,"
"expected to," "expects to," "will continue," "anticipated,"
"estimate," "projected," "intend," "goal," or similar expressions
are intended to identify "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Such statements are subject to certain risks, known and unknown,
and uncertainties, many of which are beyond the control of the
Company. Such uncertainties and risks include, but are not
limited to, the satisfaction of customary closing conditions, our
ability to successfully execute our growth strategy, changes in
laws or regulations, including final rules implemented under the No
Surprises Act and related regulatory guidance, economic conditions,
dependence on management, dilution to stockholders, lack of
capital, the effects of rapid growth upon the Company and the
ability of management to effectively respond to the growth and
demand for products and services of the Company, newly developing
technologies, the Company's ability to compete, conflicts of
interest in related party transactions, regulatory matters,
protection of technology, lack of industry standards, the effects
of competition and the ability of the Company to obtain future
financing. An extensive list of factors that can affect future
results are discussed in the Annual Report on Form 10-K for the
year ended December 31, 2022 and the
Current Reports on Form 10-Q for the periods ended March 20, 2023, June 30,
2023, and September 30, 2023
under the heading "Risk Factors" in Part I, Item IA thereof, and
other documents filed from time to time with the Securities and
Exchange Commission. Such factors could materially adversely affect
the Company's financial performance and could cause the Company's
actual results for future periods to differ materially from any
opinions or statements expressed within this press release.
View original
content:https://www.prnewswire.com/news-releases/nutex-health-announces-pricing-of-10-0-million-registered-direct-offering-of-common-stock-and-warrants-302041657.html
SOURCE Nutex Health, Inc.